Reverse fosmidomycin derivatives against the antimalarial drug target IspC (Dxr).
Behrendt CT, Kunfermann A, Illarionova V, Matheeussen A, Pein MK, Gräwert T, Kaiser J, Bacher A, Eisenreich W, Illarionov B, Fischer M, Maes L, Groll M, Kurz T.
Behrendt CT, et al. Among authors: maes l.
J Med Chem. 2011 Oct 13;54(19):6796-802. doi: 10.1021/jm200694q. Epub 2011 Sep 13.
J Med Chem. 2011.
PMID: 21866890